Vertex Pharmaceuticals (VRTX) Ownership
VRTX$547.03-0.86 -0.16%
Market cap$138.69BEnterprise value$140.66BRevenue (TTM)$12.99BMarket positionTop 25%
Score
47
Neutral
Value
16
Quality
85
Growth
41
Ownership data loads after the page opens.
Vertex Pharmaceuticals (VRTX) Ownership
VRTX price $547.03 -0.86 -0.16%
- Ticker
- VRTX
- Price
- $547.03
- Change
- -0.86 -0.16%
- Market cap
- $138.69B
- P/E
- 34.94
- Forward P/E
- 29.13
- Dividend yield
- 0.00%
- Beta
- 0.32
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 47
- Value
- 16
- Quality
- 85
- Growth
- 41
Stocklytics score rationale: value 16, quality 85, growth 41.
AI Score 85. Vertex Pharmaceuticals has a strong market capitalization of $134.5 billion and impressive profit margins, including a net profit margin of 30.6%. The company also maintains a robust clinical pipeline and has shown consistent revenue growth, with quarterly revenues reaching $3.44 billion recently, indicating solid fundamentals and growth potential
Insights · Forecast · Financials · Learn